Fmr LLC Orasure Technologies Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Fmr LLC holds 18,478 shares of OSUR stock, worth $78,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,478

Previous 18,318 0.87%

Holding current value

$78,346

Previous $112,000 30.36%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.2 - $6.18 $672 - $988	160 Added 0.87%	18,478 $78,000
Q1 2024 May 13, 2024	BUY	$6.08 - $8.28 $15,181 - $20,675	2,497 Added 15.78%	18,318 $112,000
Q4 2023 Feb 13, 2024	BUY	$5.13 - $8.35 $559 - $910	109 Added 0.69%	15,821 $129,000
Q3 2023 Nov 13, 2023	SELL	$4.4 - $6.91 $352 - $552	-80 Reduced 0.51%	15,712 $93,000
Q2 2023 Aug 11, 2023	SELL	$4.88 - $7.39 $2,888 - $4,374	-592 Reduced 3.61%	15,792 $79,000
Q1 2023 May 11, 2023	BUY	$4.66 - $6.52 $1,057 - $1,480	227 Added 1.4%	16,384 $99,000
Q4 2022 Feb 13, 2023	BUY	$3.7 - $5.29 $1,872 - $2,676	506 Added 3.23%	16,157 $77,000
Q3 2022 Nov 10, 2022	BUY	$2.72 - $4.61 $13,502 - $22,884	4,964 Added 46.45%	15,651 $59,000
Q2 2022 Aug 12, 2022	BUY	$2.71 - $7.12 $20,677 - $54,325	7,630 Added 249.59%	10,687 $29,000
Q1 2022 May 13, 2022	BUY	$6.62 - $9.33 $18,681 - $26,329	2,822 Added 1200.85%	3,057 $21,000
Q3 2021 Nov 15, 2021	BUY	$9.73 - $13.38 $2,014 - $2,769	207 Added 739.29%	235 $2,000
Q2 2021 Aug 13, 2021	BUY	$9.02 - $11.68 $252 - $327	28 New	28 $0

Others Institutions Holding OSUR

# of Institutions

218

Shares Held

67.1M

Call Options Held

8.5K

Put Options Held

11.8K

View Full List

About ORASURE TECHNOLOGIES INC

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $308M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

More about OSUR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account